The State of Preventive Cardiology

August 28, 2020
Kevin Kunzmann

A podcast interview with the president of American Society of Preventive Cardiology, on the eve of the ESC 2020 Congress.

The European Society of Cardiology (ESC) 2020 Congress begins this weekend, offering a completely virtual 4000-plus abstract agenda spanning 5 days of world-leading cardiovascular and cardiometabolic disease discussion.

Despite coronavirus 2019 (COVID-19) pushing the international annual meeting to online confines this year, investigators and presenters have anticipated the usual gravity of new findings and collaboration among the ever-busy cardiology field will be felt nonetheless.

After all, in many ways, cardiovascular disease was very recently the most pressing public health issue in the US—and the boom of constantly developing, massively-scaled research that has come to highlight meetings like ESC have reflected the significance of that issue.

This year’s HCPLive® coverage of ESC 2020 focuses on the very necessary topic of preventive cardiology; video interviews, session coverage, and breaking data reporting will highlight progression in the screening, diagnosing, and management of cardiovascular-risk patients.

This episode of DocTalk provides a primer of that coverage.

Amit Khera, MD, president of the American Society of Preventive Cardiology (ASPC), joined for a discussion on the current state of cardiology prevention care and research, the advancement of management therapies and telemedicine tools, and lessons learned from overseeing the virtual ASPC meeting this summer.

“Prevention itself is not young, but the field of specialists in preventive cardiology is,” he explained. “At ASPC, we’re working to find out more, and hopefully get more trainees involved in that. Not the field of prevention in general, but the discipline of preventive cardiology is sharpening, and hopefully we get more and more people entering the discipline as the years go on.”